| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| FINAFLOXACIN DISCONTINUED
| FINAFLOXACIN | ANTIINFECTIVES | OTIC | Cmax 0.58 NANOMOLAR SOLUBILITY SLIGHTLY SOLUBLE IN WATER (0.125 MILLIGRAM / MILLILITER) | DNA GYRASE TOPOISOMERASE IV | DNA GYRASE INHIBITOR CHEMBL3038482 DNA GYRASE P0A0K8 DNA GYRASE SUBUNIT B STAPHYLOCOCCUS AUREUS ENZYME | EMA | |||
